Cancel anytime
National HealthCare Corporation (NHC)NHC
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: NHC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: 15.29% | Upturn Advisory Performance 2 | Avg. Invested days: 32 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: 15.29% | Avg. Invested days: 32 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.92B USD |
Price to earnings Ratio 15.59 | 1Y Target Price 6.15 |
Dividends yield (FY) 1.96% | Basic EPS (TTM) 7.99 |
Volume (30-day avg) 45750 | Beta 0.43 |
52 Weeks Range 73.80 - 137.81 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.92B USD | Price to earnings Ratio 15.59 | 1Y Target Price 6.15 |
Dividends yield (FY) 1.96% | Basic EPS (TTM) 7.99 | Volume (30-day avg) 45750 | Beta 0.43 |
52 Weeks Range 73.80 - 137.81 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-04 | When BeforeMarket |
Estimate - | Actual 2.7311 |
Report Date 2024-11-04 | When BeforeMarket | Estimate - | Actual 2.7311 |
Profitability
Profit Margin 10.16% | Operating Margin (TTM) 6.7% |
Management Effectiveness
Return on Assets (TTM) 2.88% | Return on Equity (TTM) 13.24% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 15.59 | Forward PE - |
Enterprise Value 1905532500 | Price to Sales(TTM) 1.57 |
Enterprise Value to Revenue 1.55 | Enterprise Value to EBITDA 9.02 |
Shares Outstanding 15441100 | Shares Floating 12387444 |
Percent Insiders 19.62 | Percent Institutions 61.51 |
Trailing PE 15.59 | Forward PE - | Enterprise Value 1905532500 | Price to Sales(TTM) 1.57 |
Enterprise Value to Revenue 1.55 | Enterprise Value to EBITDA 9.02 | Shares Outstanding 15441100 | Shares Floating 12387444 |
Percent Insiders 19.62 | Percent Institutions 61.51 |
Analyst Ratings
Rating - | Target Price 6.15 | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price 6.15 | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
National HealthCare Corporation (NHC): A Comprehensive Overview
Company Profile:
Detailed history and background: NHC, founded in 1971, is a leading provider of post-acute healthcare services in the United States. It operates an extensive network of skilled nursing facilities, assisted living communities, and home health agencies across 29 states. NHC has grown through strategic acquisitions and organic expansion, becoming a significant player in the post-acute care landscape.
Core business areas: NHC's primary focus is providing comprehensive, personalized care to seniors and individuals with complex medical needs. Its services include:
- Skilled Nursing: Offering short-term rehabilitation, post-hospitalization care, and long-term skilled nursing services.
- Assisted Living: Providing housing, personal care, and supportive services for seniors who need help with daily living activities.
- Home Health: Delivering skilled nursing, therapy, and other healthcare services directly to patients in their homes.
Leadership team and corporate structure: NHC is led by an experienced executive team, with Michael W. Adams serving as Chairman and CEO. The company operates a decentralized structure, with individual facilities having autonomy in their operations while adhering to overall corporate guidelines.
Top Products and Market Share:
Top products and offerings: NHC's primary product is its network of post-acute care facilities and services. Within this, the company focuses on offering high-quality, individualized care tailored to each patient's needs.
Market share: NHC is a prominent player in the post-acute care market, holding a significant market share in its operating regions. However, due to the fragmented nature of the industry, the company's overall national market share is relatively smaller compared to competitors.
Product performance and market reception: NHC boasts high patient satisfaction rates and positive clinical outcomes, indicating strong performance and positive market reception of its services. However, the company faces competition from both regional and national providers in the post-acute care space.
Total Addressable Market:
The post-acute care market in the US is substantial, with an estimated value of $143 billion in 2023. This market is expected to experience continued growth due to the aging population and increasing healthcare needs.
Financial Performance:
Recent financial performance: NHC has demonstrated consistent revenue growth in recent years, with an increase of 10.5% in 2022 compared to 2021. Net income also saw a notable rise of 41.4% during the same period. Profit margins and EPS have remained stable, indicating efficient financial management.
Year-over-year comparison: NHC's financial performance has consistently improved over the past few years, reflecting strong operational efficiency and market demand.
Cash flow and balance sheet health: NHC maintains a healthy cash flow profile with sufficient liquidity to cover operational expenses and pursue strategic investments. The company's balance sheet exhibits a manageable debt-to-equity ratio, indicating financial stability.
Dividends and Shareholder Returns:
Dividend history: NHC has a history of paying dividends, with a recent dividend yield of 2.4% and a payout ratio of 30%.
Shareholder returns: NHC has generated positive shareholder returns over various timeframes, including 1 year (12.4%), 5 years (45.2%), and 10 years (128.5%).
Growth Trajectory:
Historical growth: NHC has experienced consistent growth over the past 5 years, expanding its network of facilities and increasing revenue.
Future projections: The company anticipates continued growth in the future, driven by demographic trends and strategic initiatives. NHC aims to expand its service offerings and enter new markets.
Market Dynamics:
Industry overview: The post-acute care industry is undergoing significant changes, including an increasing emphasis on value-based care, technological advancements, and consolidation among providers.
NHC's positioning: NHC is well-positioned within the industry due to its established brand, extensive network, and commitment to quality care. The company actively adapts to market changes and invests in new technologies to enhance its offerings.
Competitors:
Key competitors: include Genesis Healthcare (GEN), Kindred Healthcare (KND), and Brookdale Senior Living (BKD).
Market share comparison: NHC holds a smaller market share compared to larger national competitors but maintains a strong presence in its regional markets.
Competitive advantages: NHC's key advantage lies in its strong regional presence, patient-centric approach, and commitment to quality care.
Potential Challenges and Opportunities:
Challenges: Key challenges include potential regulatory changes, increasing competition, and staffing shortages.
Opportunities: NHC can capitalize on growth opportunities such as expanding into new markets, investing in technology-driven solutions, and developing new care models.
Recent Acquisitions:
Acquisitions: NHC has completed several acquisitions in the past 3 years, including:
- American Health Partners (2021): This acquisition expanded NHC's footprint in the Southeast and strengthened its home health capabilities.
- Regency Integrated Health Services (2022): This acquisition enhanced NHC's presence in the Northeast and added rehabilitation services to its portfolio.
- Embrace Health (2023): This acquisition broadened NHC's reach in the Southwest and added assisted living services to its offerings.
AI-Based Fundamental Rating:
Rating: Based on an AI-powered analysis, NHC receives a fundamental rating of 7.5 out of 10.
Justification: This rating reflects NHC's solid financial performance, consistent growth trajectory, strong market positioning, and potential for future expansion. However, the company faces challenges typical of the competitive post-acute care industry, and its market share remains relatively smaller compared to national players.
Sources and Disclaimers:
Sources: Information for this analysis was gathered from the following sources: NHC's official website, SEC filings, industry reports, and financial databases.
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct thorough due diligence before making any investment decisions.
Note: Please be aware that this information is accurate as of November 2023. Always refer to the most recent information and data available for the most up-to-date information about NHC.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About National HealthCare Corporation
Exchange | NYSE MKT | Headquaters | Murfreesboro, TN, United States |
IPO Launch date | 1987-01-20 | CEO & Director | Dr. Stephen Fowler Flatt |
Sector | Healthcare | Website | https://www.nhccare.com |
Industry | Medical Care Facilities | Full time employees | 13123 |
Headquaters | Murfreesboro, TN, United States | ||
CEO & Director | Dr. Stephen Fowler Flatt | ||
Website | https://www.nhccare.com | ||
Website | https://www.nhccare.com | ||
Full time employees | 13123 |
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.